Clinical Trial Update: A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 dose-response clinical trial investigating bevifibatide for acute ischemic stroke is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Bevifibatide (bevifibatide)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Ischemic Stroke, Acute, Ischemic Stroke | Phase 2 | Status: RECRUITING